Skip to content

Just ACT for Student Well-being

Just ACT: School-Based Program Using Acceptance and Commitment Therapy (ACT) to Promote Student Well-being

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06971861
Enrollment
96
Registered
2025-05-14
Start date
2025-06-04
Completion date
2028-10-21
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptance and Commitment Therapy, Psychological Well-being

Brief summary

Most psychological conditions start developing during adolescent years. This makes adolescence an ideal and critical window for prevention efforts that help enhance stress management and mental health among the younger generations. This pilot study aims to develop a brief prevention program that focuses on youths' well-being and living as guided by their personal values.

Interventions

BEHAVIORALAcceptance and Commitment Therapy

The current program is based on ACT and consists of four one-hour sessions covering the six core components of psychological flexibility. The four sessions respectively focus on Cognitive Defusion, Being Present and Acceptance, Self-as-Context and Values, and Committed Action. All sessions involve experiential learning activities and reflective discussions. Each participant also receives a workbook to facilitate post-session home practice.

Sponsors

New Life Psychiatric Rehabilitation Association
CollaboratorOTHER
The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* age of 35 years or below * fluency in oral and written Chinese

Exclusion criteria

* active or current history of psychosis, bipolar disorder, or personality disorder * active or current report of suicidal attempts * active or current suicidal ideations for more than half the days * any history of intellectual deficits

Design outcomes

Primary

MeasureTime frameDescription
AttendanceAt the end of treatmentAttendance across four sessions in percentage
Change in psychological flexibility as measured with the Multidimensional Psychological Flexibility InventoryBefore treatment, between the second and third session, within one week after treatment, and one month after treatmentThe Multidimensional Psychological Flexibility Inventory (MPFI; Rolffs et al., 2018) is the only validated measure that provides separate ratings on the six core processes of ACT (see Barrett et al., 2019). Items are rated on a 6-point Likert scale, from 1 - Never True to 6 - Always True, and averaged to obtain a score for each of the dimensions.

Secondary

MeasureTime frameDescription
Change in depressive symptoms as measured with Patient Health Questionnaire (PHQ-9)Before treatment, within a week after treatment, and one month after treatmentThe nine-item Patient Health Questionnaire (PHQ-9; Kroenke & Spitzer, 2002) is a gold-standard measure of depressive symptoms an individual experienced in the prior two-week period. Items are rated on a 4-point Likert scale, from 0 - Not at All to 3 - Nearly Every Day. Total score on the PHQ-9 ranges from 0 to 27, with higher scores indicating more severe impact of depressive symptoms on an individual's life.
Treatment retentionAt the end of treatmentPercentage of participants staying in treatment through the end
Treatment satisfactionWithin a week after treatmentParticipants are invited to rate on a 5-point Likert scale, from 1 - Strongly Disagree to 5 - Strongly Agree, designed specifically to assess their level of satisfaction with the intervention received in the current study. They are also asked in an open-ended way to provide qualitative feedback on the program, including their overall or any specific experience with the program not otherwise captured by the pre-set prompting questions.
Change in anxiety symptoms as measured with the Generalized Anxiety Disorder (GAD-7)Before treatment, within a week after treatment, and one month after treatmentThe seven-item Generalized Anxiety Disorder (GAD-7; Spitzer et al., 2006) is a gold-standard measure of anxiety symptoms an individual experienced in the prior two-week period. Items are rated on a 4-point Likert scale, from 0 - Not at All to 3 - Nearly Every Day. Total score on the GAD-7 ranges from 0 to 21, with higher scores indicating more severe impact of anxiety symptoms on an individual's life.
Change in well-being as measured with the Flourishing ScaleBefore treatment, within a week after treatment, and one month after treatmentThe Flourishing Scale (FS) is an 8-item rating scale that measures sociopsychological prosperity, in terms of social relationships, purposeful or meaningful living, self-respect, and feeling of competence. Items are rated on a 7-point Likert scale, from 1 - Strong Disagreement to 7 - Strong Agreement.

Countries

Hong Kong

Contacts

Primary ContactDirector
idpclab@hku.hk+852-39175889

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026